封面
市场调查报告书
商品编码
1308925

数位治疗市场:依适应症、成分、分布划分 - 2023-2030 年全球预测

Digital Therapeutics Market by Indication, Component, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球数位治疗市场将达46.5809亿美元,复合年复合成长率高达23.80%,预计2030年将达到207.9266亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球数位治疗市场至关重要。透过检查业务策略和产品满意度的关键指标,我们对供应商进行全面评估,使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限,并取得了不同程度的成功:前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献,可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解:

1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2. 市场开发:提供有关利润丰厚的新兴市场的详细资讯,并分析其在成熟市场的渗透率。

3. 市场多元化:提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势:全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题:

1. 数位疗法的全球市场规模和预测是多少?

2. 在预测期内,COVID-19 塑造全球数位治疗市场的阻碍因素和影响是什么?

3. 在预测期内,全球数位治疗市场需要投资哪些产品/细分市场/应用/领域?

4.全球数位治疗市场的竞争策略是什么?

5. 全球数位治疗市场的技术趋势和法律规范是什么?

6. 全球数位治疗市场主要厂商的市占率是多少?

7. 哪些型态和策略措施被认为适合进入全球数位治疗市场?

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 预防慢性病发生率增加
      • 使用带有医疗保健应用程式的智慧型手机和平板电脑
      • 政府推动远端医疗和远端医疗的倡议
    • 抑制因素
      • 新兴经济体对数位疗法的认知有限
    • 机会
      • 增加资金筹措和投资以拓展数位健康业务
      • 数位治疗新技术
    • 任务
      • 资料隐私和安全问题
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章依适应症分類的数位治疗市场

  • 循环系统疾病
  • 中枢神经系统疾病
  • 慢性呼吸道疾病
  • 糖尿病
  • 药物依从性
  • 肌肉骨骼疾病
  • 肥胖
  • 糖尿病前期
  • 禁止抽烟

第7章数位治疗市场:按组成部分

  • 装置
  • 软体

第8章按分布分類的数位治疗市场

  • B2B
    • 雇主
    • 付款人
    • 製药公司
    • 提供者
  • B2C
    • 照顾者
    • 病人

第9章美洲数位治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太数字治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲数位治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析:主要企业
  • 竞争情境分析:主要企业
    • 併购

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-431752EA472E

The Global Digital Therapeutics Market is forecasted to grow significantly, with a projected USD 4,658.09 million in 2023 at a CAGR of 23.80% and expected to reach a staggering USD 20,792.66 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Digital Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Digital Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Cardiovascular Disease, Central Nervous System Disorder, Chronic Respiratory Disease, Diabetes, Medication Adherence, Musculoskeletal Disorder, Obesity, Prediabetes, and Smoking Cessation. The Obesity is projected to witness significant market share during forecast period.

Based on Component, market is studied across Devices and Software. The Devices is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across B2B and B2C. The B2B is further studied across Employer, Payer, Pharmaceutical Company, and Provider. The B2C is further studied across Caregiver and Patient. The B2B is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Digital Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Digital Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Digital Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Digital Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Digital Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Digital Therapeutics Market?

6. What is the market share of the leading vendors in the Global Digital Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Digital Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Digital Therapeutics Market, by Indication, 2022 vs 2030
  • 4.3. Digital Therapeutics Market, by Component, 2022 vs 2030
  • 4.4. Digital Therapeutics Market, by Distribution, 2022 vs 2030
  • 4.5. Digital Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of preventive chronic diseases
      • 5.1.1.2. Adoption of smartphones and tablets coupled with healthcare apps
      • 5.1.1.3. Government initiatives promoting telehealth and telemedicine
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness regarding digital therapeutics in the developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising funding and investments for expanding digital health businesses
      • 5.1.3.2. New technologies in digital therapeutics
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy and security concerns
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Digital Therapeutics Market, by Indication

  • 6.1. Introduction
  • 6.2. Cardiovascular Disease
  • 6.3. Central Nervous System Disorder
  • 6.4. Chronic Respiratory Disease
  • 6.5. Diabetes
  • 6.6. Medication Adherence
  • 6.7. Musculoskeletal Disorder
  • 6.8. Obesity
  • 6.9. Prediabetes
  • 6.10. Smoking Cessation

7. Digital Therapeutics Market, by Component

  • 7.1. Introduction
  • 7.2. Devices
  • 7.3. Software

8. Digital Therapeutics Market, by Distribution

  • 8.1. Introduction
  • 8.2. B2B
    • 8.2.1. Employer
    • 8.2.2. Payer
    • 8.2.3. Pharmaceutical Company
    • 8.2.4. Provider
  • 8.3. B2C
    • 8.3.1. Caregiver
    • 8.3.2. Patient

9. Americas Digital Therapeutics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Therapeutics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Therapeutics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Pfizer in Early Stage Talks to Acquire Seagen

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DIGITAL THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL THERAPEUTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
  • FIGURE 5. DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 6. DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
  • FIGURE 7. DIGITAL THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DIGITAL THERAPEUTICS MARKET DYNAMICS
  • FIGURE 9. DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DIGITAL THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DIGITAL THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 5. DIGITAL THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL THERAPEUTICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DIGITAL THERAPEUTICS MARKET SIZE, BY CHRONIC RESPIRATORY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DIGITAL THERAPEUTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DIGITAL THERAPEUTICS MARKET SIZE, BY MEDICATION ADHERENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DIGITAL THERAPEUTICS MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DIGITAL THERAPEUTICS MARKET SIZE, BY OBESITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DIGITAL THERAPEUTICS MARKET SIZE, BY PREDIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DIGITAL THERAPEUTICS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 15. DIGITAL THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DIGITAL THERAPEUTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 18. DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 19. DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DIGITAL THERAPEUTICS MARKET SIZE, BY EMPLOYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DIGITAL THERAPEUTICS MARKET SIZE, BY PAYER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. DIGITAL THERAPEUTICS MARKET SIZE, BY PHARMACEUTICAL COMPANY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DIGITAL THERAPEUTICS MARKET SIZE, BY PROVIDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 25. DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. DIGITAL THERAPEUTICS MARKET SIZE, BY CAREGIVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. DIGITAL THERAPEUTICS MARKET SIZE, BY PATIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY B2B, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM DIGITAL THERAPEUTICS MARKET SIZE, BY B2C, 2018-2030 (USD MILLION)
  • TABLE 237. DIGITAL THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 238. DIGITAL THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 239. DIGITAL THERAPEUTICS MARKET LICENSE & PRICING